Oncoclínicas do Brasil Serviços Médicos S.A. (ONCO3) reported in a material fact on Tuesday, September 29, 2026, that its Board of Directors received on September 24, 2026 a request from shareholder UBS Lumen Fundo de Investimento Financeiro em Ações – Responsabilidade Limitada to call an Extraordinary General Meeting (EGM).
According to the document, UBS Lumen is asking that the EGM resolve on changing the composition of the Board of Directors, removing the current members, setting the number of board members at 7, and electing new members to replace those eventually removed, in addition to adopting any other actions necessary to implement these decisions.
Oncoclínicas also reported that the Board of Directors has taken note of the request to call the EGM and that the matter remains under review, with no resolution so far. The company stated that it will keep shareholders and the market informed of any material developments.
